Optimal insulin regimens in type 2 diabetes mellitus

Systematic review and meta-analyses

D. S. Lasserson, P. Glasziou, R. Perera, R. R. Holman, A. J. Farmer

Research output: Contribution to journalArticleResearchpeer-review

93 Citations (Scopus)

Abstract

Aims/hypothesis: We compared the effect of biphasic, basal or prandial insulin regimens on glucose control, clinical outcomes and adverse events in people with type 2 diabetes. Methods: We searched the Cochrane Library, MEDLINE, EMBASE and major American and European conference abstracts for randomised controlled trials up to October 2008. A systematic review and meta-analyses were performed. Results: Twenty-two trials that randomised 4,379 patients were included. Seven trials reported both starting insulin dose and titration schedules. Hypoglycaemia definitions and glucose targets varied. Meta-analyses were performed pooling data from insulin-naive patients. Greater HbA 1c reductions were seen with biphasic and prandial insulin, compared with basal insulin, of 0.45% (95% CI 0.19-0.70, p=0.0006) and 0.45% (95% CI 0.16-0.73, p=0.002), respectively, but with lesser reductions of fasting glucose of 0.93 mmol/l (95% CI 0.21-1.65, p=0.01) and 2.20 mmol/l (95% CI 1.70-2.70, p<0.00001), respectively. Larger insulin doses at study end were reported in biphasic and prandial arms compared with basal arms. No studies found differences in major hypoglycaemic events, but minor hypoglycaemic events for prandial and biphasic insulin were inconsistently reported as either higher than or equivalent to basal insulin. Greater weight gain was seen with prandial compared with basal insulin (1.86 kg, 95% CI 0.80-2.92, p=0.0006). Conclusions/interpretation: Greater HbA1c reduction may be obtained in type 2 diabetes when insulin is initiated using biphasic or prandial insulin rather than a basal regimen, but with an unquantified risk of hypoglycaemia. Studies with longer follow-up are required to determine the clinical relevance of this finding.

Original languageEnglish
Pages (from-to)1990-2000
Number of pages11
JournalDiabetologia
Volume52
Issue number10
DOIs
Publication statusPublished - Oct 2009
Externally publishedYes

Fingerprint

Type 2 Diabetes Mellitus
Meta-Analysis
Insulin
Meals
Biphasic Insulins
Hypoglycemia
Hypoglycemic Agents
Glucose
MEDLINE
Libraries
Weight Gain
Fasting
Appointments and Schedules
Randomized Controlled Trials

Cite this

Lasserson, D. S. ; Glasziou, P. ; Perera, R. ; Holman, R. R. ; Farmer, A. J. / Optimal insulin regimens in type 2 diabetes mellitus : Systematic review and meta-analyses. In: Diabetologia. 2009 ; Vol. 52, No. 10. pp. 1990-2000.
@article{a6e0604ffce14daa85cfedd6ea6d3fd7,
title = "Optimal insulin regimens in type 2 diabetes mellitus: Systematic review and meta-analyses",
abstract = "Aims/hypothesis: We compared the effect of biphasic, basal or prandial insulin regimens on glucose control, clinical outcomes and adverse events in people with type 2 diabetes. Methods: We searched the Cochrane Library, MEDLINE, EMBASE and major American and European conference abstracts for randomised controlled trials up to October 2008. A systematic review and meta-analyses were performed. Results: Twenty-two trials that randomised 4,379 patients were included. Seven trials reported both starting insulin dose and titration schedules. Hypoglycaemia definitions and glucose targets varied. Meta-analyses were performed pooling data from insulin-naive patients. Greater HbA 1c reductions were seen with biphasic and prandial insulin, compared with basal insulin, of 0.45{\%} (95{\%} CI 0.19-0.70, p=0.0006) and 0.45{\%} (95{\%} CI 0.16-0.73, p=0.002), respectively, but with lesser reductions of fasting glucose of 0.93 mmol/l (95{\%} CI 0.21-1.65, p=0.01) and 2.20 mmol/l (95{\%} CI 1.70-2.70, p<0.00001), respectively. Larger insulin doses at study end were reported in biphasic and prandial arms compared with basal arms. No studies found differences in major hypoglycaemic events, but minor hypoglycaemic events for prandial and biphasic insulin were inconsistently reported as either higher than or equivalent to basal insulin. Greater weight gain was seen with prandial compared with basal insulin (1.86 kg, 95{\%} CI 0.80-2.92, p=0.0006). Conclusions/interpretation: Greater HbA1c reduction may be obtained in type 2 diabetes when insulin is initiated using biphasic or prandial insulin rather than a basal regimen, but with an unquantified risk of hypoglycaemia. Studies with longer follow-up are required to determine the clinical relevance of this finding.",
author = "Lasserson, {D. S.} and P. Glasziou and R. Perera and Holman, {R. R.} and Farmer, {A. J.}",
year = "2009",
month = "10",
doi = "10.1007/s00125-009-1468-7",
language = "English",
volume = "52",
pages = "1990--2000",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer",
number = "10",

}

Optimal insulin regimens in type 2 diabetes mellitus : Systematic review and meta-analyses. / Lasserson, D. S.; Glasziou, P.; Perera, R.; Holman, R. R.; Farmer, A. J.

In: Diabetologia, Vol. 52, No. 10, 10.2009, p. 1990-2000.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Optimal insulin regimens in type 2 diabetes mellitus

T2 - Systematic review and meta-analyses

AU - Lasserson, D. S.

AU - Glasziou, P.

AU - Perera, R.

AU - Holman, R. R.

AU - Farmer, A. J.

PY - 2009/10

Y1 - 2009/10

N2 - Aims/hypothesis: We compared the effect of biphasic, basal or prandial insulin regimens on glucose control, clinical outcomes and adverse events in people with type 2 diabetes. Methods: We searched the Cochrane Library, MEDLINE, EMBASE and major American and European conference abstracts for randomised controlled trials up to October 2008. A systematic review and meta-analyses were performed. Results: Twenty-two trials that randomised 4,379 patients were included. Seven trials reported both starting insulin dose and titration schedules. Hypoglycaemia definitions and glucose targets varied. Meta-analyses were performed pooling data from insulin-naive patients. Greater HbA 1c reductions were seen with biphasic and prandial insulin, compared with basal insulin, of 0.45% (95% CI 0.19-0.70, p=0.0006) and 0.45% (95% CI 0.16-0.73, p=0.002), respectively, but with lesser reductions of fasting glucose of 0.93 mmol/l (95% CI 0.21-1.65, p=0.01) and 2.20 mmol/l (95% CI 1.70-2.70, p<0.00001), respectively. Larger insulin doses at study end were reported in biphasic and prandial arms compared with basal arms. No studies found differences in major hypoglycaemic events, but minor hypoglycaemic events for prandial and biphasic insulin were inconsistently reported as either higher than or equivalent to basal insulin. Greater weight gain was seen with prandial compared with basal insulin (1.86 kg, 95% CI 0.80-2.92, p=0.0006). Conclusions/interpretation: Greater HbA1c reduction may be obtained in type 2 diabetes when insulin is initiated using biphasic or prandial insulin rather than a basal regimen, but with an unquantified risk of hypoglycaemia. Studies with longer follow-up are required to determine the clinical relevance of this finding.

AB - Aims/hypothesis: We compared the effect of biphasic, basal or prandial insulin regimens on glucose control, clinical outcomes and adverse events in people with type 2 diabetes. Methods: We searched the Cochrane Library, MEDLINE, EMBASE and major American and European conference abstracts for randomised controlled trials up to October 2008. A systematic review and meta-analyses were performed. Results: Twenty-two trials that randomised 4,379 patients were included. Seven trials reported both starting insulin dose and titration schedules. Hypoglycaemia definitions and glucose targets varied. Meta-analyses were performed pooling data from insulin-naive patients. Greater HbA 1c reductions were seen with biphasic and prandial insulin, compared with basal insulin, of 0.45% (95% CI 0.19-0.70, p=0.0006) and 0.45% (95% CI 0.16-0.73, p=0.002), respectively, but with lesser reductions of fasting glucose of 0.93 mmol/l (95% CI 0.21-1.65, p=0.01) and 2.20 mmol/l (95% CI 1.70-2.70, p<0.00001), respectively. Larger insulin doses at study end were reported in biphasic and prandial arms compared with basal arms. No studies found differences in major hypoglycaemic events, but minor hypoglycaemic events for prandial and biphasic insulin were inconsistently reported as either higher than or equivalent to basal insulin. Greater weight gain was seen with prandial compared with basal insulin (1.86 kg, 95% CI 0.80-2.92, p=0.0006). Conclusions/interpretation: Greater HbA1c reduction may be obtained in type 2 diabetes when insulin is initiated using biphasic or prandial insulin rather than a basal regimen, but with an unquantified risk of hypoglycaemia. Studies with longer follow-up are required to determine the clinical relevance of this finding.

UR - http://www.scopus.com/inward/record.url?scp=69949134085&partnerID=8YFLogxK

U2 - 10.1007/s00125-009-1468-7

DO - 10.1007/s00125-009-1468-7

M3 - Article

VL - 52

SP - 1990

EP - 2000

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 10

ER -